By Dhirendra Tripathi
Investing.com – Bayer (DE: BAYGN ) stock traded 2.7% higher Monday in Frankfurt after reports that Singapore’s Temasek, a long-term investor, is calling for the removal of Chief Executive Officer Werner Baumann.
Temasek has had longstanding concerns about Bayer’s operating performance under Baumann and the company’s lack of succession planning, grievances the state investor has communicated to the company, Bloomberg said.
According to the report, among the options Temasek is considering ahead of the shareholder meeting next month are requesting a no-confidence vote in Baumann or voting against ratifying the performance of the management. Either step would significantly raise pressure on Bayer’s board to rejig the leadership.
Temasek’s activist-type approach is rare for the firm. It built a roughly 4% stake in the German company in 2018, helping Bayer (OTC: BAYRY ) complete the controversial $63 billion takeover of Monsanto (NYSE: MON ). The deal, championed by Baumann, has cost the company billions of dollars in litigation amid charges that Monsanto’s product Roundup causes cancer.
Swiss investor Alatus has already objected to ratifying the performance of Baumann and his management team at Bayer’s April 29 meeting, pointing to a significant loss in market value during his tenure. Bayer shares have lost 39% since the Monsanto deal closed but are up 29% so far this year, according to Bloomberg.
Alatus, whose letter has been posted on Bayer’s website, said the company has failed to lay out a strategy that produces long-term growth for the crop science and pharmaceutical divisions. It also called for allowing shareholders to vote on members of Bayer’s management team individually at the meeting, rather than collectively.
Investor frustration with leadership could also trigger Bayer to revisit calls to break itself up into agriculture, pharmaceutical, and consumer healthcare units.
Add Chart to Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
- Enrich the conversation
- Stay focused and on track. Only post material that’s relevant to the topic being discussed.
- Be respectful. Even negative opinions can be framed positively and diplomatically.
- Use standard writing style. Include punctuation and upper and lower cases.
- NOTE: Spam and/or promotional messages and links within a comment will be removed
- Avoid profanity, slander or personal attacks directed at an author or another user.
- Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
- Only English comments will be allowed.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.